Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease

Movement Disorders

Volumn 27, Issue 13, 2012, Pages 1625-1631

  Buchman, Aron S ^a,b   Nag, Sukriti ^a,b   Shulman, Joshua M ^c,d   Lim, Andrew S P ^e   Vanderhorst, Veronique G J M ^d,f   Leurgans, Sue E ^a,b   Schneider, Julie A ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Locus coeruleus; Parkinson's disease; Parkinsonism; Substantia nigra

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL DENSITY; CEREBROVASCULAR DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DORSAL RAPHE NUCLEUS; FEMALE; HUMAN; LOCUS CERULEUS; MALE; NERVE CELL; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; VENTRAL TEGMENTUM;

AGED; AGED, 80 AND OVER; AGING; AMYLOID; CELL COUNT; FEMALE; HUMANS; LEWY BODIES; LOCUS COERULEUS; MALE; NEURONS; PARKINSONIAN DISORDERS; POSTMORTEM CHANGES; PSYCHIATRIC STATUS RATING SCALES;

EID: 84870346708     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25142     Document Type: Article

References (26)

1. Louis ED, Bennett DA. Mild Parkinsonian signs: An overview of an emerging concept. Mov Disord 2007; 22: 1681-1688.
2. Louis ED, Tang MX, Schupf N. Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Disord 2010; 25: 172-178.
3. Zhou G, Duan L, Sun F, Yan B, Ren S. Association between mild parkinsonian signs and mortality in an elderly male cohort in China. J Clin Neurosci 2010; 17: 173-176.
4. Buchman AS, Leurgans SE, Boyle PA, Schneider JA, Arnold SE, Bennett DA. Combinations of motor measures more strongly predict adverse health outcomes in old age: the Rush Memory and Aging Project, a Community-Based Cohort Study. BMC Medicine 2011; 9: 42.
5. Greffard S, Verny M, Bonnet A-M, et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006; 63: 584-588.
6. Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009; 8: 1150-1157.
7. Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003; 60: 337-341.
8. Braak H, Tredici KD, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
9. Buchman AS, Shulman JM, Nag S, et al. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol 2012; 71: 258-266.
10. Ross GW, Petrovitch H, Abbott RD, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 2004; 56: 532-539.
11. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
12. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and Findings From the Rush Memory and Aging Project. Curr Alzheimer Res 2012.
13. Bennett DA, Shannon KM, Beckett LA, Wilson RS. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 1999; 54: M191-M196.
14. DeArmond SJ, Fusco MM, Dewey MM. Structure of the Human Brain. A Photographic Atlas. 3rd ed. Oxford, UK: Oxford University Press; 1989.
15. Bennett DA, Schneider JA, Tang Y, Arnold SE, Wilson RS. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol 2006; 5: 406-412.
16. SAS/STAT Software for Unix, version 9.18 [computer program]. Cary, NC: SAS Institute Inc.; 2002- 2003.
17. US Census Bureau News Report. Dramatic Changes in U.S. Aging. 2006. Available at: http://www.census.gov/newsroom/releases/archives/aging_population/cv06-36.html.
18. Brunton L, Chabner B, Knollman B. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill Professional; 2011.
19. Dickson D, Fujishiro H, DelleDonne A, et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008; 115: 437-444.
20. DelleDonne A, Klos KJ, Fujishiro H, et al. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 2008; 65: 1074-1080.
21. Frigerio R, Fujishiro H, Maraganore DM, et al. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 2009; 66: 1114-1119.
22. Rommelfanger KS, Weinshenker D. Norepinephrine: the redheaded stepchild of Parkinson's disease. Biochem Pharmacol 2007; 74: 177-190.
23. Isaias IU, Marzegan A, Pezzoli G, et al. A role for locus coeruleus in Parkinson tremor. Front Hum Neurosci 2012; 2012: 5.
24. Carter ME, Yizhar O, Chikahisa S, et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010; 13: 1526-1533.
25. Bruinstroop E, Cano G, Vanderhorst VGJM, et al. Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats. J Comp Neurol 2012; 520: 1985-2001.
26. Burke RE, Dauer WT, Vonsattel JPG. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008; 64: 485-491.